Company intelligence / Profile preview

Womize

Besançon, Bourgogne-Franche-Comté, France

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Womize is a French biotechnology company dedicated to revolutionizing women's health through advanced vaginal microbiome science. The company develops targeted prebiotic and probiotic solutions designed to restore and maintain a healthy vaginal ecosystem, addressing common conditions such as bacterial vaginosis and recurrent infections. By leveraging a proprietary research platform, Womize aims to provide non-antibiotic alternatives that promote long-term gynecological wellness. Their approach combines clinical rigor with a focus on patient-centric care in the rapidly growing femtech sector.

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: Live biotherapeutic product therapyPrebiotics
Industry: Biotech

Beyond the preview

Go deeper on Womize.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Womize.

Explore the full profile